Search results for "Data"

showing 10 items of 12992 documents

La inteligencia artificial, la robótica autónoma y el big data en la narrativa de una Europa unida en la diversidad

2021

La literatura científica que se ha generado sobre la integración de Europa suele centrarse en investigaciones que se desarrollaron poco después de finalizar la II Guerra Mundial en los ámbitos social, político y económico. Con esta tesis doctoral se incorpora una aproximación desde la ciencia y la tecnología que trata de comprender cómo se han construido socialmente la inteligencia artificial, la robótica autónoma y el big data en Europa entre 1950 y 2019. ¿Puede reconocerse alguna narrativa basada en estas tecnologías que hubiese influido en el proceso de integración de los Estados europeos? ¿Emergió algún estilo tecnológico de la inteligencia artificial genuino de la Unión Europea? Damos …

:CIENCIAS TECNOLÓGICAS [UNESCO]UNESCO::HISTORIAinteligencia artificialeconomíaéticarobótica autónomasistemas tecnológicoslegislaciónpolítica:MATEMÁTICAS::Ciencia de los ordenadores [UNESCO]UNESCO::CIENCIAS TECNOLÓGICAShistóriaconstrucción social tecnologíaindustriaUNESCO::FILOSOFÍAbig dataUnión Europea:FILOSOFÍA [UNESCO]UNESCO::MATEMÁTICAS::Ciencia de los ordenadorestecnología:HISTORIA [UNESCO]Europamedicina
researchProduct

Diseño e implementación de una aplicación en Processing para la representación visual de datos multidimensionales utilizando técnicas de Minería de D…

2015

La posibilidad de disponer de representaciones gráficas de los datos es de gran valor a la hora de extraer conocimiento útil. Sus principales ventajas son la visualización de información de una forma sencilla, rápida y directa. No obstante, muchos de los conjuntos de datos contienen numerosos registros, que pueden ser de naturaleza multivariante. En estos casos, la representación visual de datos se convierte en una tarea complicada y las técnicas clásicas que suelen utilizarse obtienen resultados poco intuitivos. Esta tesis se plantea como objetivo el diseño e implementación de una aplicación versátil capaz de representar visualmente gran cantidad de datos multidimensionales de forma eficaz…

:CIENCIAS TECNOLÓGICAS [UNESCO]manifoldrepresentaciónmineríaclasificaciónVDEUNESCO::CIENCIAS TECNOLÓGICASreduccióndimensionalidadenviromentdatosdataentornovisualprocessingmultidimensional
researchProduct

Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycl…

2009

Background The prevalence of and risk factors for central nervous system recurrence in patients with acute promyelocytic leukemia are not well established and remain a controversial matter. Design and Methods Between 1996 and 2005, 739 patients with newly diagnosed acute promyelocytic leukemia enrolled in two consecutive trials (PETHEMA LPA96 and LPA99) received induction therapy-with all-trans retinoic acid and idarubicin. Consolidation therapy comprised three courses of anthracycline monochemotherapy (LPA96), with all-trans retinoic acid and reinforced doses of idarubicin in patients with an intermediate or high risk of relapse (LPA99). Central nervous system prophylaxis was not given. Re…

:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Idarubicin [Medical Subject Headings]:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Male:Named Groups::Persons::Age Groups::Adult::Middle Aged [Medical Subject Headings]idarubicinGastroenterology:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Central Nervous System NeoplasmsLeukemia Promyelocytic AcuteRecurrenceRisk FactorsCumulative incidenceAntibiotics AntineoplasticHematologyMiddle Agedall-trans retinoic acidLeukemiamedicine.anatomical_structure:Named Groups::Persons::Age Groups::Adolescent [Medical Subject Headings]Femalemedicine.drugAcute promyelocytic leukemiaAdultcentral nervous system relapsemedicine.medical_specialty:Diseases::Neoplasms::Neoplasms by Histologic Type::Leukemia::Leukemia Myeloid::Leukemia Myeloid Acute [Medical Subject Headings]AnthracyclineAdolescentCentral nervous system:Check Tags::Male [Medical Subject Headings]TretinoinNeoplasias del sistema nervioso centralCentral nervous system diseaseTretinoinInternal medicine:Named Groups::Persons::Age Groups::Adult [Medical Subject Headings]medicineIdarubicinHumans:Named Groups::Persons::Age Groups::Adult::Aged [Medical Subject Headings]Letters to the Editor:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Acyclic::Alkenes::Polyenes::Carotenoids::Retinoids [Medical Subject Headings]Leucemia promielocítica agudaAgedAntibióticos antineoplásicosbusiness.industryprognostic factors:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antibiotics Antineoplastic [Medical Subject Headings]acute promyelocytic leukemiamedicine.diseaseSurgery:Diseases::Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms [Medical Subject Headings]:Check Tags::Female [Medical Subject Headings]businessIdarubicin
researchProduct

Posttraumatic carotid-cavernous fistula: Pathogenetic mechanisms, diagnostic management and proper treatment. A case report.

2016

Journal Article; UNLABELLED Carotid-cavernous fistulas are an uncommon diseases characterized by abnormal communications between arteries and veins located in the cavernous sinus. According with Barrow´s classification they could be divided in two groups: direct and indirect. The typical symptoms showed by theses pathologies are: pulsating exophthalmos and orbital blow. The present study describes a case of direct posttraumatic carotid-cavernous fistula in a 26 years old man. Furthermore, we present the images that we used to make the diagnosis. In this light, we decided to treat this case with endovascular approach after considering several therapeutic options. The aim of the present repor…

:Diseases::Eye Diseases::Orbital Diseases::Exophthalmos [Medical Subject Headings]medicine.medical_specialtyPulsating exophthalmosFistula:Check Tags::Male [Medical Subject Headings]Case ReportOdontologíaOrbital blowExoftalmia:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]03 medical and health sciencesVenas0302 clinical medicine:Diseases::Cardiovascular Diseases::Vascular Diseases::Cerebrovascular Disorders::Carotid Artery Diseases::Carotid-Cavernous Sinus Fistula [Medical Subject Headings]Pulsating exophthalmosmedicineRare syndrome:Anatomy::Cardiovascular System::Blood Vessels::Arteries [Medical Subject Headings]030212 general & internal medicine:Anatomy::Cardiovascular System::Blood Vessels::Veins::Cranial Sinuses::Cavernous Sinus [Medical Subject Headings]General DentistryCarotid-cavernous fistulaOral Medicine and Pathologybusiness.industryCarotid cavernous fistulasSeno cavernosoEndovascular approachmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludBarrow´s classification.SurgeryCavernous sinusUNESCO::CIENCIAS MÉDICAScardiovascular systemProper treatmentbusinessFístula del seno cavernoso de la carótida:Anatomy::Cardiovascular System::Blood Vessels::Veins [Medical Subject Headings]030217 neurology & neurosurgery
researchProduct

Perspectives for the Treatment of Brucellosis in the 21st Century: The Ioannina Recommendations

2007

Policy Forum. Competing interests: ER has received research grants from Daiichi, Bayer, and Theravance and has served as a consultant to Pfizer, Theravance, Bayer, Wyeth, Rosetta, and BiondVax. Summary Points Brucellosis remains the commonest anthropozoonosis worldwide, and its treatment remains complex, requiring protracted administration of more than one antibiotic. In November 2006, a consensus meeting aimed at reaching a common specialist statement on the treatment of brucellosis was held in Ioannina, Greece under the auspices of the International Society of Chemotherapy and the Institute of Continuing Medical Education of Ioannina. The author panel suggests that the optimal treatment o…

:Diseases::Pathological Conditions Signs and Symptoms::Pathologic Processes::Disease Attributes::Recurrence [Medical Subject Headings]Veterinary medicine:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Streptomycin [Medical Subject Headings]:Phenomena and Processes::Microbiological Phenomena::Drug Resistance Microbial [Medical Subject Headings]DiseaseGlobal Health:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Health Care::Population Characteristics::Health::World Health [Medical Subject Headings]Terminología como AsuntoBrucellosi:Organisms::Eukaryota::Animals [Medical Subject Headings]:Health Care::Health Care Economics and Organizations::Organizations::International Agencies::United Nations::World Health Organization [Medical Subject Headings]Policy ForumMedicine in Developing CountriesGentamicinasDrug Resistance MicrobialBrucelosisAdhesión a DirectrizGeneral MedicineHumanosDrug CombinationsAntibacterianosDoxycyclineStreptomycinEstreptomicinaMedicine:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds with 4 or More Rings::Rifamycins::Rifampin [Medical Subject Headings]Drug Therapy CombinationGuideline AdherenceRifampinFluoroquinolonesSalud Mundialmedicine.medical_specialtyEfficacyResultado del TratamientoInvestigación BiomédicaRecurrenciaTherapeuticsWorld Health OrganizationMicrobiologyAntibiotic resistanceTerminology as Topic:Disciplines and Occupations::Social Sciences::Internationality::International Cooperation::Developing Countries [Medical Subject Headings]HumansMedical journalIntensive care medicineDeveloping Countries:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 1-Ring::Pyrimidines::Trimethoprim::Trimethoprim-Sulfamethoxazole Combination [Medical Subject Headings]medicine.diseaseCotrimoxazoleAnimalesQuimioterapia:Humanities::Humanities::History::History Modern 1601-::History 21st Century [Medical Subject Headings]GentamicinsBrucel·losiBiomedical ResearchCommunicable diseases:Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds 2-Ring::Quinolines::Quinolones::Fluoroquinolones [Medical Subject Headings]Human diseaseRecurrence:Chemicals and Drugs::Pharmaceutical Preparations::Drug Combinations [Medical Subject Headings]:Information Science::Information Science::Communication::Language::Linguistics::Terminology as Topic [Medical Subject Headings]biologyIraqi patientsRMetaanalysis:Diseases::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Negative Bacterial Infections::Brucellosis [Medical Subject Headings]Historia del Siglo XXIAnti-Bacterial AgentsCombinación Trimetoprim-SulfametoxazolTreatment OutcomeInfectious Diseases:Disciplines and Occupations::Natural Science Disciplines::Science::Research::Biomedical Research [Medical Subject Headings]:Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons Cyclic::Hydrocarbons Aromatic::Polycyclic Hydrocarbons Aromatic::Naphthacenes::Tetracyclines::Doxycycline [Medical Subject Headings]Fluoroquinolonas:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [Medical Subject Headings]:Chemicals and Drugs::Carbohydrates::Glycosides::Aminoglycosides::Gentamicins [Medical Subject Headings]Países en Desarrollo:Analytical Diagnostic and Therapeutic Techniques and Equipment::Therapeutics::Drug Therapy::Drug Therapy Combination [Medical Subject Headings]BrucellaHistory 21st CenturyBrucellosisWorld healthTrimethoprim Sulfamethoxazole Drug CombinationmedicineAnimals:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis::Treatment Outcome [Medical Subject Headings]Resistencia a Medicamentosbusiness.industryOrganización Mundial de la SaludBrucellosisMalalties infecciosesTerapèuticabiology.organism_classificationCombinación de MedicamentosDoxiciclinaTherapybusinessBrucella melitensisPLoS Medicine
researchProduct

Patients' and physicians' preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a discrete choice experiment.

2015

Objective: To assess Spanish and Portuguese patients' and physicians' preferences regarding type 2 diabetes mellitus (T2DM) treatments and the monthly willingness to pay (WTP) to gain benefits or avoid side effects. Methods: An observational, multicenter, exploratory study focused on routine clinical practice in Spain and Portugal. Physicians were recruited from multiple hospitals and outpatient clinics, while patients were recruited from eleven centers operating in the public health care system in different autonomous communities in Spain and Portugal. Preferences were measured via a discrete choice experiment by rating multiple T2DM medication attributes. Data were analyzed using the cond…

:Geographicals::Geographic Locations::Europe::Portugal [Medical Subject Headings]cardiovascular riskHbA1cendocrine system diseases:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Physical Examination::Body Constitution::Body Weights and Measures::Body Mass Index [Medical Subject Headings]:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Hypoglycemia [Medical Subject Headings]:Disciplines and Occupations::Health Occupations::Medicine::Public Health [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Probability::Risk::Risk Factors [Medical Subject Headings]:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]:Named Groups::Persons::Occupational Groups::Health Personnel::Physicians [Medical Subject Headings]HbA(1c)HbA:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Body Weight::Body Weight Changes::Weight Loss [Medical Subject Headings]:Diseases::Cardiovascular Diseases [Medical Subject Headings]preferences:Geographicals::Geographic Locations::Europe::Spain [Medical Subject Headings]diabetesnutritional and metabolic diseasesPeso corporalweightPérdida de peso:Health Care::Health Care Facilities Manpower and Services::Health Facilities::Ambulatory Care Facilities [Medical Subject Headings]Diabetes mellitus tipo 2:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Signs and Symptoms Digestive::Nausea [Medical Subject Headings]hypoglycemia:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Models Statistical::Logistic Models [Medical Subject Headings]:Diseases::Pathological Conditions Signs and Symptoms::Signs and Symptoms::Body Weight [Medical Subject Headings]:Diseases::Nutritional and Metabolic Diseases::Metabolic Diseases::Glucose Metabolism Disorders::Diabetes Mellitus::Diabetes Mellitus Type 2 [Medical Subject Headings]:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Hypoglycemic Agents [Medical Subject Headings]Enfermedades cardiovascularesHipoglucemiawillingness to pay:Check Tags [Medical Subject Headings]discrete choice model
researchProduct

Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey

2022

Infection control; Multidrug resistance; Stewardship Control de infección; Resistencia a múltiples fármacos; Administración Control d'infecció; Resistència a múltiples fàrmacs; Administració We explored the self-reported antibiotic stewardship (AS), and infection prevention and control (IPC) activities in intensive care units (ICUs) of different income settings. A cross-sectional study was conducted using an online questionnaire to collect data about IPC and AS measures in participating ICUs. The study participants were Infectious Diseases–International Research Initiative (IDI-IR) members, committed as per their institutional agreement form. We analyzed responses from 57 ICUs in 24 countri…

:Investigative Techniques::Epidemiologic Methods::Data Collection::Surveys and Questionnaires [ANALYTICAL DIAGNOSTIC AND THERAPEUTIC TECHNIQUES AND EQUIPMENT]EpidemiologyIntensive Care UnitInfection controlAmerica:acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antibacterianos [COMPUESTOS QUÍMICOS Y DROGAS]Multidrug resistanceCommunicable DiseasesEnquestesPan drug resistanceCommunicable DiseaseAntimicrobial StewardshipSurveys and QuestionnairesAnti-Bacterial AgentHumansMedicaments antibacterians - Ús terapèuticStewardshipSurveys and QuestionnaireSocietyUnitats de cures intensivesCross-Sectional StudieInfection ControlCross InfectionPreventionPublic Health Environmental and Occupational Health:técnicas de investigación::métodos epidemiológicos::recopilación de datos::encuestas y cuestionarios [TÉCNICAS Y EQUIPOS ANALÍTICOS DIAGNÓSTICOS Y TERAPÉUTICOS]General MedicineMDROAnti-Bacterial AgentsIntensive Care Units:Health Care Facilities Manpower and Services::Health Facilities::Hospital Units::Intensive Care Units [HEALTH CARE]Cross-Sectional StudiesInfectious Diseases:instalaciones servicios y personal de asistencia sanitaria::centros sanitarios::unidades hospitalarias::unidades de cuidados intensivos [ATENCIÓN DE SALUD]:Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Anti-Bacterial Agents [CHEMICALS AND DRUGS]Self ReportMDROsLow- and upper-middle and high incomeHuman
researchProduct

ATLAS data quality operations and performance for 2015-2018 data-taking

2020

The ATLAS detector at the Large Hadron Collider reads out particle collision data from over 100 million electronic channels at a rate of approximately 100 kHz, with a recording rate for physics events of approximately 1 kHz. Before being certified for physics analysis at computer centres worldwide, the data must be scrutinised to ensure they are clean from any hardware or software related issues that may compromise their integrity. Prompt identification of these issues permits fast action to investigate, correct and potentially prevent future such problems that could render the data unusable. This is achieved through the monitoring of detector-level quantities and reconstructed collision ev…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]DATAPhysics - Instrumentation and DetectorsPhysics::Instrumentation and DetectorsData managementdetector-systems performance01 natural sciencesSERVICEHigh Energy Physics - ExperimentSubatomär fysik//purl.org/becyt/ford/1 [https]High Energy Physics - Experiment (hep-ex)SoftwareCERNSubatomic Physics[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]InstrumentationMathematical PhysicsOperationLarge detector-systems performanceSettore FIS/01Data processingLarge Hadron ColliderAtlas (topology)ROOT-S=13 TEVDetectorInstrumentation and Detectors (physics.ins-det)ATLASGNAM:Nuclear and elementary particle physics: 431 [VDP]qualityLarge detector systems for particle and astroparticle physics; Large; detector-systems performance; ROOT-S=13 TEV; COLLISIONS; SERVICE; SEARCH; GNAMParticle Physics - ExperimentperformanceCOLLISIONS530 PhysicsCiências Naturais::Ciências FísicasReal-time computing:Ciências Físicas [Ciências Naturais]610FOS: Physical sciencesprogrammingSEARCH0103 physical sciencesddc:610High Energy Physics[PHYS.PHYS.PHYS-INS-DET]Physics [physics]/Physics [physics]/Instrumentation and Detectors [physics.ins-det]010306 general physicsScience & TechnologyLarge detector systems for particle and astroparticle physics; Large detector-systems performance010308 nuclear & particles physicsbusiness.industryLarge detector systems for particle and astroparticle physicsData quality//purl.org/becyt/ford/1.3 [https]Collision530 PhysikmonitoringefficiencyData qualityExperimental High Energy PhysicsLarge detector systems for particle and astroparticle physicLargedata managementbusiness
researchProduct

Particle identification in ALICE: a Bayesian approach

2016

We present a Bayesian approach to particle identification (PID) within the ALICE experiment. The aim is to more effectively combine the particle identification capabilities of its various detectors. After a brief explanation of the adopted methodology and formalism, the performance of the Bayesian PID approach for charged pions, kaons and protons in the central barrel of ALICE is studied. PID is performed via measurements of specific energy loss ($\mathrm{d}E/\mathrm{d}x$) and time-of-flight. PID efficiencies and misidentification probabilities are extracted and compared with Monte Carlo simulations using high-purity samples of identified particles in the decay channels ${\rm K}^0_S \righta…

:Kjerne- og elementærpartikkelfysikk: 431 [VDP]Monte Carlo methodGeneral Physics and AstronomyPID controllerPP01 natural sciencesParticle identificationHigh Energy Physics - ExperimentParticle identificationHigh Energy Physics - Experiment (hep-ex)ALICEHadron-Hadron scattering (experiments)Heavy-ion collisionNuclear and High Energy Physics Hadron-Hadron scattering (experiments) Heavy Ion Experiments Heavy-ion collision Quark gluon plasma Particle identification Bayesianscattering [p p][PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]Nuclear Experiment (nucl-ex)Detectors and Experimental TechniquesNuclear ExperimentNuclear ExperimentPhysicsefficiency [particle identification]PB COLLISIONSVDP::Kjerne- og elementærpartikkelfysikk: 431Monte Carlo [numerical calculations]PB COLLISIONS PP PERFORMANCE.:Mathematics and natural scienses: 400::Physics: 430::Nuclear and elementary particle physics: 431 [VDP]PRIRODNE ZNANOSTI. Fizika.Time of flight:Nuclear and elementary particle physics: 431 [VDP]VDP::Nuclear and elementary particle physics: 431performancemomentum spectrum [charged particle]Nuclear and High Energy PhysicsParticle physicsMesoneducationBayesian probabilityFOS: Physical sciencesQuark gluon plasma[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]114 Physical sciencesBayesianNuclear physicsPhysics and Astronomy (all)PionHeavy Ion Experiments0103 physical sciencesddc:530010306 general physics010308 nuclear & particles physicsBayesian approach:Matematikk og naturvitenskap: 400::Fysikk: 430::Kjerne- og elementærpartikkelfysikk: 431 [VDP]ALICE experimentPERFORMANCEparticle identification ; Bayesian approachNATURAL SCIENCES. Physics.PB COLLISIONS; TEV; PP; PERFORMANCEPhysics - Data Analysis Statistics and ProbabilityQuark–gluon plasmaBayesian [statistics]TEVHigh Energy Physics::Experimentparticle identificationData Analysis Statistics and Probability (physics.data-an)
researchProduct

Electronic identity verification: personal data protection challenges and risks

2020

This work highlights the clash of GDPR, eIDAS Regulation and PSD2 Directive, as well as tackles challenges of implementation in practice, specifically the challenges of securing personal data whilst ensuring an electronic identity. A comparative analysis on practical case studies which are concerned with electronic identity verification, electronic identity establishment and use electronic identity verification in the process of providing services is carried out in order to understand how such businesses tackle personal data challenges, how successfully and to what manner. The work concludes with findings of legal uncertainty between all three regulatory acts, as they lack unified definitio…

:LAW/JURISPRUDENCE::Other law::European law [Research Subject Categories]Data protection
researchProduct